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Abstract
Bovine leukemia virus (BLV) is an oncogenic virus widespread in cattle. It belongs to the genus Deltaretrovirus of the family Retroviridae
along with human and simian T-lymphotropic viruses. Here we report the addition of 28 new sequences to the current literature of 16 full-length
BLV envelope gene sequences. The phylogenetic clustering, genotyping, and geographic distribution of BLV env variations corresponded in most
cases. Most natural variations are mapped to the surface of the proposed conformational models of BLV gp51 N-terminus and gp30 external
domain, overlapping with or adjacent to immunogenic epitopes. Analyses for evidence of possible selection pressures suggest the BLV env is
under stringent negative selection overall, while strong positive selection is indicated for immunogenic epitope G. Natural env deletions bounded
by similar flanking sequences were observed in multiple isolates and would result in truncated signal peptides, missing gp51, and aberrant coding
frames for other proteins.
© 2007 Elsevier Inc. All rights reserved.Keywords: Bovine leukemia virus; env; Polymorphism; Phylogeny; Selection; Conformational model; DeletionIntroduction
Bovine leukemia virus (BLV) infects cattle worldwide and
imposes severe financial impacts on the cattle industry. As a
retrovirus, BLV has envelope (Env) proteins which contain
functional domains that determine its infectivity (Johnston et al.,
2002). BLV Env protein complex is composed of surface
glycoprotein subunit (SU), which is anchored to the envelope
via disulfide bonding (Johnston and Radke, 2000) with
transmembrane glycoprotein subunit (TM). The newly synthe-
sized BLV Env polyprotein precursor is cleaved into 3 pieces in
the Golgi apparatus of the virus-producing cell: leader (signal)
peptide (amino acid [aa] 1–33), SU (aa34–301), and TM (aa302–☆ GenBank Accession Nos.: Nucleotide sequence data from this article have
been deposited with the GenBank Data Libraries under Accession No.
EF065635–EF065662.
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doi:10.1016/j.virol.2007.03.058515). Oligomers of mature Env proteins are transported to the host
cell surface membrane, where they are inserted. Viral particles bud
at these insertion sites, acquiring an envelope with Env proteins in
the process. In mature virions, SU peplomers recognize and bind
to cell surface receptors, initiating a series of conformational
changes that lead to the fusion of viral envelope and cellular
surface membranes via TM oligomers. This is followed by the
entry of the viral genome into the cell, digestion of the viral
capsid, synthesis of the DNA provirus, integration into host
genome (not necessarily occurring), and expression of viral genes.
The structure and functions of the BLVEnv proteins have been
extensively studied via delineation of conformational epitopes
recognized by monoclonal antibodies (Bruck et al., 1982;
Callebaut et al., 1991; Ban et al., 1992), and via identification
by antipeptide antibodies (targeting linear epitopes) that block
syncytium formation or neutralize the infectivity of pseudotype
virus (Portetelle et al., 1989a; Callebaut et al., 1993). The N-
terminal half of mature BLV gp51 SU plays an important role in
viral infectivity and syncytium formation (Portetelle et al., 1989b;
Callebaut et al., 1993), and probably contains the receptor-binding
domain (Johnston et al., 2002). Also located there are the
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1982), whose recognition by specific monoclonal antibodies
depends on disulfide bonding (Portetelle et al., 1989b) and
glycosylation (Bruck et al., 1984).Monoclonal antibodies specific
for the F, G, and H epitopes bound differentially to BLV Env
proteins with slightly different amino acid sequences, leading to
the identification of amino acids potentially affecting SU
conformation (Portetelle et al., 1989b; Mamoun et al., 1990).
The C-terminal half of BLV gp51 SU (Figs. 1 and 2) contains
linear epitopes A, B, D, and E, mapped with antipeptide
antibodies. This segment of SU also interacts with TM, probably
via a disulfide bond (Johnston and Radke, 2000) formed between
a conserved CXXC (X refers to any amino acid; Fig. 2) motif in
SU (Gallaher et al., 1995) and a conserved CX6CC motif in TM
(Rice et al., 1984; Fig. 2).
The BLV gp30 TM (Figs. 1 and 2; Table 2) contains an
extracellular domain (N-terminal) encompassing the hydropho-
bic fusion peptide (Gatot et al., 1998), a 4-3 heptad repeat
(leucine zipper) (Gatot et al., 1998), and the GD21 peptide
(Hadlock et al., 1995; Dube et al., 1997); a middle transmem-
brane domain hosting a stretch of 20 uncharged residues
(aa438–457) spanning the host cell membrane before budding
(Rice et al., 1984); and a cytoplasmic domain (C-terminal)
including PXXP motifs (Cantor, 1996; Reichert et al., 2001)
interspersed with YXXL immunoreceptor tyrosine activation
motifs (ITAMs) (Inabe et al., 1999; Novakovic et al., 2004).
In contrast to many other retroviruses, e.g. human immuno-
deficiency virus-1 (HIV-1) (Liu et al., 2006), analyses of the
BLV env gene sequences of isolates with different geographic
origins demonstrated a high sequence conservation (Camargos
et al., 2002, 2006). However, alterations in Env protein
sequence resulting from non-synonymous nucleotide substitu-
tions, although not frequent, could affect BLV infectivity and/or
pathogenicity (Willems et al., 1995, 2000; Fechner et al., 1997).Fig. 1. The BLV genome. The length of each genomic region is not drawn to scal
sequences of corresponding Env epitopes/functional domains. The solid black rectang
2, and 3. See Fig. 2 and Table 2 for more details of the amino acid sequences and lo
rectangle labeled with an asterisk refers to the coding region shared by env with the
locations of PCR-amplified env segments are indicated at the bottom. Annotations
epitopes; CD4+: CD4+ T cell epitope; CD8+: CD8+ T cell epitope; CTM: cytoplasmi
protein subunits; F, G, H: conformational epitopes; FP: fusion peptide; gag: gag gen
retroviral polymerase gene encoding reverse transcriptase; prot: prot gene encoding
all having two (5′ and 3′) coding regions as shown.BLV belongs to the Deltaretrovirus genus which also
includes primate (human/simian) T-cell lymphotropic viruses
(PTLVs): HTLV-1, -2 and -3, STLV-1, -2 and -3. Phylogeneti-
cally, BLVand PTLVs share a common ancestor. Studies on the
BLV genetic diversity and its implications are not only of
interest for veterinary medicine (e.g. pathogenicity, diagnosis,
and vaccine development), but also for the possibility of viral
transmission to other species including human (Buehring et al.,
2003). So far there have been 16 full-length BLV env sequences
deposited in sequence databanks (e.g. GenBank) by multiple
research groups over 23 years. Here we report 28 newly
determined full-length BLV env sequences, from field isolates
collected from 4 different continents. Analyses for phylogenetic
clustering, genotyping, and evidence of possible selection
across as well as within clusters were conducted for a sample
pool containing all those 44 full-length BLV env sequences
available to date. Homology modeling for BLV gp51 N-
terminus and gp30 external domain provided a hint of the
possible spatial distribution of sequence variations. Natural
extensive deletions in gp51 coding sequence, bound by similar
flanking sequences, were observed in some samples and the
possible biological effects of this are discussed.
Results and discussion
Variations were detected in BLV env gene and deduced Env
protein sequences
All cattle from which BLV isolates were obtained were
determined to be BLV-positive by serological tests (enzyme-
linked immunosorbent assay, immunoblotting, and/or agar gel
immunodiffusion assay) performed in the country of origin
(data not shown). Twenty-eight full-length BLV env sequences
were obtained by nested PCR amplification, followed bye. The labeled rectangles in the upper panel (the env gene) refer to the coding
les labeled 1, 2, and 3 refer to the coding sequences of neutralization domains 1,
cations of Env epitopes/functional domains. In the lower panel, the solid black
5′ R3 and rex genes (nt4821–4871), and the 5′ tax gene (nt4868–4871). The
: 20aa: coding sequence of the uncharged 20 amino acids; A, B, D, E: linear
c domain of the transmembrane protein; env: env gene encoding viral envelope
e encoding viral nucleocapsid protein subunits; LTR: long terminal repeats; pol:
protease protein; tax, rex, G4, and R3: genes encoding BLV regulatory proteins,
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Table 1). In addition, we included in our analyses 16 full-length
BLV env sequences already reported by other research groups
and available in the GenBank database. Out of those 44 full-
length BLV env sequences, 271 of 1548 nucleotide sites
(17.51%) showed a point variation from the consensus in at
least one isolate. The nucleotide variability (number of
variations per site) in an individual isolate ranged from
0.064% (1/1548; CR AG-2) to 4.005% (62/1548; CR LV),
with an average at 1.66% (25.68/1548). For the 28 newly
sequenced isolates, their env gene showed nucleotide variability
of 0.064% to 4.005%, with an average at 1.49%.
Forty-four deduced full-length amino acid sequences of BLV
Env were aligned with their consensus sequence, with
annotation of the functional domains identified to date (Fig.
2). Some large tracts of amino acid sequences, e.g. CD4+ and
CD8+ T cell epitopes in SU and 4-3 heptad repeat and GD21 in
TM, were highly conserved among isolates from different
countries (Fig. 2) and were all located to the outward surface of
the corresponding Env subunits in our conformational models
(data not shown), thus might be of importance in designing env
peptide-derived BLV vaccines (Daniel et al., 1993; Hadlock et
al., 1995). Some small Env amino acid variations were shown to
induce incomplete cross-reactivity among HTLV-1 strains and
induce specific neutralizing antibodies (Blanchard et al., 1999),
suggesting the important application of elucidating deltaretro-
viral sequence variability, viz. vaccine development and disease
control. In our case, the BLV Env amino acid sequences were
deduced from corresponding nucleotide sequences determined
in seropositive cattle. Further information, e.g. whether sera
from those animals are cross-reactive, are capable of recogniz-
ing heterogeneous Env regions, or are targeted to the tracts of
conserved amino acid sequences, would be helpful in
determining the possible applications of those BLV Env
variability data.
In this study, variations in the deduced amino acid sequence
were observed within, as well as outside, BLV Env functional
domains. Some of the amino acid variations showed a trend of
geographic clustering, e.g. I15V in only and most Costa Rican
isolates (Fig. 2). To better evaluate the clustering pattern of BLV
Env/env variations, we further did phylogenetic analyses and
genotyping.
The phylogenetic clustering, genotyping, and geographic
distribution of BLV env variations matched each other in most
cases
The phylogenetic tree based on full-length BLV env
nucleotide sequences (neighbor-joining method with 1000
bootstrapping replications, MEGA 3.1) showed the grouping
of isolates into 4 main clusters located in different areas
worldwide: US Californian, European, Costa Rican, and
consensus (showing least variation from consensus sequence)
(Fig. 3). The phylogenetic tree based on deduced full-length
BLV Env amino acid sequences with neighbor-joining method
showed the same clustering and very similar bootstrapping
values (data not shown). Trees obtained by the Minimum-Evolution method in MEGA 3.1 showed exactly the same
topology (data not shown). The phylogenetic clustering roughly
matched the geographic distribution of the donor cattle of BLV
isolates (viral sources) (Fig. 3), consistent with the idea of BLV
transmission via close contact among cattle, and reflective of the
general migration trend of BLV hosts among different areas. For
example, Japan used to import cattle from the USA, some of
which could have been already BLV-positive at the time of
importation. Consistently, the US and Japanese BLV isolates
were phylogenetically grouped together, in either the US CA
cluster or the consensus cluster. Seven among the nine Costa
Rican isolates have consistently constituted a separate mono-
phyletic group, based on BLV env/Env in this study, LTR (Zhao
et al., 2007a), or regulatory gene/protein sequences (Zhao et al.,
2007b). We currently do not have any idea about the reason why
the other twoCosta Rican isolates (CRAG-2 andCRAS-3) were
consistently excluded from the CR monophyletic cluster, other
than proposing that their host cattle might be recent additions to
the herds close to the time of sample collection, and the BLV
genotypes were more consistent with the original parental herds
than the new herds to which the animals were transferred.
Genotyping based on restriction fragment length polymorph-
ism (RFLP) has been frequently used for a general idea on
genomic composition when detailed sequence information is
not available. Genotypes using deduced RFLP on 444-bp partial
BLV env sequence (nt5099–5542), by 5 restrictive enzymes as
described previously (Fechner et al., 1997), were determined for
each isolate (Table 1). In another previous study (Licursi et al.,
2002), although RFLP was performed using the same five
restriction enzymes, only three (BclI, HaeIII, and PvuII) were
used for genotyping. RFLP, although based on partial sequence
in these cases, can provide supplementary information to full
length-based phylogenetic clustering. For example, isolate JP-
K02120 (Sagata et al., 1985) was determined to be genotype B/
3 together with JP MI-1, -2 and -3 (isolates from this study),
unlike the other isolates in the consensus group (genotype C/1)
(Table 1). Coincidentally, those four isolates were collected
from geographically adjacent prefectures in Japan (Iwate and
Miyagi). To evaluate how well the two clustering methods, the
phylogeny based on the full-length BLV env gene vs.
genotyping based on partial env sequences (Fechner et al.,
1997), matched each other, we further calculated the percentage
of “matched pairs”. For each random pair of isolates, if they
were clustered together by both methods or if they were
consistently separated into two groups by those two methods,
they were defined as a “match pair”. Out of all 946 (=44×43 /2)
possible pairs of the 44 isolates, 747 pairs (78.96%) matched,
supporting the idea that those two clustering methods
(phylogeny and genotyping) corresponded in most cases
(Fig. 3; Table 1).
Selection pressures were suggested for BLV env, both globally
and locally
For the 44 full-length BLV env genes, the difference in the
overall nucleotide variability (number of variations per nucleo-
tide per isolate) among the leader peptide, gp51, and gp30 sub-
153X. Zhao, G.C. Buehring / Virology 366 (2007) 150–165coding regions was moderately significant (Friedman's test with
Dunn's post test, p=0.0266). We further conducted selection
tests on the full-length env and on each individual sub-region.When the rate of non-synonymous substitution (PN=number of
non-synonymous substitutions per non-synonymous site)
versus the rate of synonymous substitution (PS=number of
154 X. Zhao, G.C. Buehring / Virology 366 (2007) 150–165synonymous substitutions per synonymous site) were compared
(Wilcoxon matched pairs test), significant differences were
detected in total env (pb0.0001) as well as in leader peptide(pb0.005), gp51 (pb0.0001), and gp30 (pb0.0001) sequences.
The ratios of PN/PS were calculated for evidence of selection
(b1 for negative and N1 for positive selection). Negative
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ious. It can result in the maintenance of conserved genomic
sequences over long periods of evolutionary time. In compar-
ison, positive selection increases the frequency of certain
variations. The BLV env gene as a whole and all its sub-coding
regions (leader peptide, gp51, and gp30) showed negative
selection (PNbPS) (Table 2).
The possible selections on the BLV Env epitopes/functional
domains identified to date are summarized by Table 2. Several
coding sequences for functional domains (epitope F, zinc
binding cysteine, WAPE motif, CXXC motif, and CX6CC
motif) did not show a statistically significant selection (Table 2),
probably due to short sequence lengths (3–12 nucleotides).
Those coding sequences all showed reduced nucleotide
diversity and amino acid diversity (PN) compared with those
in their sequence context (gp51 or gp30 coding region),
consistent with the need of structural conservation in those
functional domains.
Negative selection was observed in the coding sequences for
most functional domains (Table 2), as expected for their
importance in sequence and conformational conservation. For
example, the gp51 zinc binding peptide, which interacts with
zinc ion and is indispensable in in vivo viral fusion (Gatot et al.,
2002), showed a mean PN/PS at 0.1946 (Pb0.005; Table 2).
Another example of stringently conserved gp51 motifs is the
specific N-linked glycosylation sites. The glycosylation mod-
ifications in retroviral SU subunits can help virus escape the
recognition by neutralizing antibodies, by masking principal
neutralizing epitopes (Chackerian et al., 1997; Cheng-Mayer et
al., 1999; Johnson et al., 2003). This idea might also be
applicable in the case of BLV Env, as indicated in our
conformational model (Fig. 4A), and is consistent with the
dramatically reduced PN/PS at 0 (Pb0.001) observed in this
study (Table 2). In the BLV TM subunit gp30, a stretch of 20
uncharged residues (aa438–457), which is believed to span host
cell membranes (Rice et al., 1984), showed a PN/PS of 0.0325
(Pb0.001; Table 2). Furthermore, all of the predicted amino
acid substitutions (L445F and F448L) within that uncharged
20aa stretch were also uncharged, sustaining its hydrophobicity.
Interestingly, K458, the first positively charged residue
following that stretch as a signal to stop the transfer of peptide
chains through a lipid membrane, showed no variation in any
sample. The same conservation is also observed for R463, the
second, “back-up” positive residue downstream to that 20aa
stretch. Other examples of highly conserved TM motifs include
the YXXL sequences, required for BLV viral entry and
incorporation of viral Env protein into virions (Inabe et al.,
1999), as well as involved in the down-regulation of the surface
exposure of BLV Env, assisting in viral evasion of adaptive
immunity (Novakovic et al., 2004). Correspondingly, YXXL
motifs showed a PN/PS at 0 (Pb0.005; Table 2).Fig. 2. The deduced Env amino acid sequences of 44 BLV isolates. In each panel,
determined in this research are shown above the 16 already published BLV Env sequ
where the amino acids match the consensus sequence. Amino acid 1 indicates the s
epitopes and functional domains. Some epitopes (F, G, andH) consist of a single amino
G, H: conformational epitopes; FR: France; JP: Japan; ND: neutralization domains; PPositive selection was observed for immunostimulatory
epitopes D/D' and G (Table 2). The extremely high PN/PS
value of G epitope is consistent with its role as a critical epitope
involved in BLV infectivity, syncytium induction, and immune
escape. Previous studies also suggested that gp51 sequence
variability might preferentially involve structural changes
underlying viral escape from immune surveillance (Molteni et
al., 1996). Interestingly, some BLV Env variants that showed
reduced binding by monoclonal antibodies specific for the
conformational epitopes F, G, and H did not show appreciably
reduced syncytium induction (Johnston et al., 2002), implying
that immuno-escape mutants could have intact pathogenicity.
Similar to epitope G, conformational epitope F also showed a
PN higher than PS (Table 2), but the difference was not
statistically significant, probably due to short sequence length (3
nucleotides). In comparison, the third conformational epitope H
showed negative selection. Such a difference among the
observed selection patterns of epitopes F, G, and H is not due
to overlapped reading frames, which affect the selection
patterns in the pXBL coding sequences of BLV (Zhao et al.,
2007b). Our survey on the charges and hydropathy index
values of the amino acids constituting or flanking those con-
formational epitopes did not reveal any special trend, either.
Currently we do not have any explanation for that difference,
other than proposing that such observed negative selection on
H conformational epitope might be artifactual due to its short
length (6 nucleotides).
The cluster-specific consensus sequences differed from the
consensus calculated for the entire sample pool (Fig. 2), thus we
further examined the possible selection in BLV env for each
individual phylogenetic group (Fig. 3). Most cluster-specific
analyses showed negative selection (Table 3), the same as for
the entire population. The comparison of relative variability
among leader peptide, gp51, and gp30, in the forms of either
overall nucleotide diversity or amino acid diversity (PN),
showed variable results in different phylogenetic clusters (Table
3), depending on the isolates included for analyses. This may
help explain the previous concern of the apparently contro-
versial results described by different research groups (Camargos
et al., 2006), where higher variability were observed for leader
peptide region in some studies but for gp51 region in others.
The BLV gp51 and gp30 conformational models map most
natural variations on the surface and spatially close to
functional domains
Advances in research on retroviral pathogenesis and
vaccine development require a better understanding of the
antigenic structure of envelope surface protein which is
directly involved in infectivity events, such as cell surface
receptor recognition and binding. To understand how the Envthe 28 full-length BLV Env sequences predicted by the nucleotide sequences
ences. The consensus sequence is shown at the top of each panel. Dots represent
tart of the BLV Env. Labeled horizontal lines indicate the position of identified
acid. AR:Argentina; AU:Australia; BE: Belgium;BR:Brazil; CR: Costa Rica; F,
L: Poland; TMHR: transmembrane hydrophobic region; US: the United States.
Table 1
BLV isolates
Samples Year Viral source PC Genotype
F L
US CA-1 1997* Davis, California, USA US CA G′ 5
US CA-2 1997* Davis, California, USA US CA G′ 5
US CA-3 1997* Davis, California, USA US CA G′ 5
JP FU 2004 Fukuoka, Japan US CA G′ 5
JP AI-1 2004 Aichi, Japan CONS C 1
JP AI-2 2004 Aichi, Japan CONS C 1
JP EH-2 2004 Ehime, Japan CONS C 1
JP MI-1 2004 Miyagi, Japan CONS B 3
JP MI-2 2004 Miyagi, Japan CONS N/A 3
JP MI-3 2004 Miyagi, Japan CONS B 3
US IA 1975* Iowa, USA CONS C 1
US ID 1994* Idaho, USA CONS C 1
US WI 1991* Wisconsin, USA CONS C 1
US PA 1976* Pennsylvania, USA CONS C 1
US-AY078387 2002 USA CONS C 1
US-M35239 1990 USA CONS C 1
US-M35242 1990 USA CONS C 1
JP KA-1 2004 Kamikawa, Japan CONS C 1
JP KA-2 2004 Kamikawa, Japan CONS C 1
JP-K02120 1985 Iwate, Japan CONS B 3
BR-AF547184 2002 Minas Gerais, Brazil CONS C 1
BR-AY151262 2002 Minas Gerais, Brazil CONS C 1
CR AG-2 2003* Guanacaste-Canas, CR CONS C 1
CR AS-3 2003* Alajuela-San Carlos, CR CONS C 1
JP EH-1 2004 Ehime, Japan CONS C 1
JP HY 2004 Hyogo, Japan CONS C 1
FR-M35238 1990 France EU A 6
PL-AF067081 1998 Poland EU A 6
BE-K02251 1984 Belgium EU A 6
BE-AF503581 1993 Belgium EU A 6
BE-M35240 1990 Belgium EU A 6
BE 2003 Belgium EU A 6
CR AG-1 2003* Alajuela-Grecia, CR CR A 6
CR GC 2003* Guanacaste-Canas, CR CR N/A N/A
CR AS-1 2003* Alajuela-San Carlos, CR CR A 6
CR AS-2 2003* Alajuela-San Carlos, CR CR A 6
CR LV 2003* Limon-Valle de la Estrella, CR CR A 6
CR LC-1 2003* Limon-Central, CR CR A 6
CR LC-2 2003* Limon-Central, CR CR A 6
BR-AF399703 2001 Northern Paran, Brazil MISC C 1
AU-D00647 1990 Australia MISC C 1
BR-AY185360 2002 Mato Grosso do Sul, Brazil MISC C 1
AR-AF257515 2000 Argentina MISC A 6
BR-AF399704 2001 Minas Gerais, Brazil MISC A 6
The full-length env sequences from the 28 bolded isolates were determined in this research, while the other 16 are all the full-length BLV env published by other
researchers. The geographic locations (viral source) of donor cattle and phylogenetic clustering (PC) of each isolate are annotated. The years when the proviral BLV-
containing genomic DNA samples were collected directly from donor cattle (bolded and asterisked), obtained as gifts from other researchers (bolded), or when the
proviral sequences were published in GenBank (regular font) are indicated. Isolates US IA and US PAwere obtained from cell lines established from BLV-positive
cattle and maintained in our laboratory, and cellular DNA samples containing BLV provirus were collected in 2005 and 1996, respectively. Predicted restriction
fragment length polymorphism (RFLP) used the five restrictive enzymes described before (Fechner et al., 1997). Genotypes were determined using RFLP from all five
enzymes (Fechner et al., 1997; column “F”) or from BclI, HaeIII, and PvuII (Licursi et al., 2003; column “L”) as described previously.
AR: Argentina; AU: Australia; BE: Belgium; BR: Brazil; CONS: consensus cluster; CR: Costa Rica; EU: European cluster; F: genotypes according to Fechner et al.,
1997; FR: France; JP: Japan; L: genotypes according to Licursi et al., 2002; MISC: miscellaneous samples; N/A: not applicable; PC: phylogenetic clustering; PL:
Poland; US: the United States; US CA: US Californian cluster.
Samples with an accession number as part of the name are already published sequences, and their geographic origins were indicated by two-letter abbreviations for
countries.
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made a model of the BLV gp51 N-terminus (aa34–186)
which holds the putative receptor binding domain (RBD), by
following the homology alignment strategy developed byJohnston et al. (2002) but using different software for
threading, viewing, and annotation. The proposed conforma-
tion (Fig. 4A) was consistent with that predicted previously
(Johnston et al., 2002). All the biochemically identified gp51
Fig. 3. Clustering of BLV isolates based on 44 full-length BLV env sequences. The phylogenetic tree shown here was constructed with the Neighbor-Joining method in
MEGA 3.1, checked with 1000 bootstrapping replications, and condensed with cut-off value at 50%. The numbers on forks indicate the percentage of times the group
consisting of the species to the right of that fork occurred among the trees, out of 1000 trees. See Table 1 for geographical origin of each isolate.
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and functional domains (neutralization domain [ND] 1, ND2,
zinc binding peptide) were mapped to the surface (Fig. 4A
and data not shown), and some (e.g. CD4+ and CD8+ T cell
epitopes) constituted joining reactive surface regions, despite
their lack of continuity in primary structure (amino acid
sequence) (data not shown). The calculated potential N-
glycosylation site (aa129–131) was also mapped to surface,
and its proposed additional carbohydrate could mask the ND2
(Fig. 4A). It is consistent with the predicted glycosylation-
mediated neutralization escape in simian immunodeficiency
virus (SIV) via shielding of principal neutralization sites
(Cheng-Mayer et al., 1999). SIV mutants with elimination of
N-glycosylation sites in their gp120 SU showed dramatically
increased sensitivity to neutralizing antibodies, partially byexposing localized epitopes (Johnson et al., 2003). In
comparison, another candidate BLV N-glycosylation site
aa67–69, which was rejected by NetNGlyc calculation, was
mapped to the face opposite of the neutralization domains
(data not shown), showing consistence between those two
computerized predictions.
In this model, all the three conformational epitopes (F, G, H),
both ND1 and ND2, and N-glycosylation site are primarily
mapped to one face of the molecule (determined as front face) or
to the edge of the opposite face (back face). Those occupied
surface areas, as proposed by Johnston et al. (2002), may be
involved in interactions with cellular surface receptors and
neutralization antibodies, thus involved in cell entry (infection)
and immunogenicity. All the 17 polymorphic informative
(variables occurring in a population over one time) N-terminal
Table 2
Tests for evidence of selection on BLV env sequences encoding epitopes and functional domains
Peptides Domains Location (aa #) References Nucleotide
variability




Overall 1–515 0.0173 0.0068 0.0489 0.1391 b0.001
Leader
Peptide
Overall 1–33 0.0199 0.0165 0.0289 0.5709 b0.005
gp51 Overall 34–301 0.0186 0.0067 0.0564 0.1188 b0.001
Immunostimulatory
epitopes
A 282–301 1, 3 0.0192 0.0155 0.0270 0.5741 b0.005
B, B′ 228–238 1, 3 0.0088 0.0048 0.0199 0.2412 b0.05
D, D′ 251–270 1, 3 0.0121 0.0128 0.0095 1.3474 b0.05 ⁎
E 175–194 1, 3 0.0444 0.0024 0.2040 0.0118 b0.001
F 95 3, 12, 15 0.0105 0.0118 0.0000 N/A NS
G 48, 73, 74, 82, 121 3, 12, 15 0.1339 0.1736 0.0314 5.5287 b0.001⁎
H 56, 58 3, 12, 15 0.0570 0.0201 0.1311 0.1533 b0.02
Neutralization domains 1 97–106 2, 5 0.0150 0.0033 0.0439 0.0752 b0.001
2 131–150 3, 2, 5 0.0182 0.0119 0.0409 0.2910 b0.001
3 210–225 3, 2, 5 0.0069 0.0000 0.0310 0.0000 b0.005
T cell epitopes CD4+ 84–113 5 0.0134 0.0021 0.0446 0.0471 b0.001
CD8+ 154–183 4, 5 0.0181 0.0017 0.0720 0.0236 b0.001
Zinc-binding peptide 137–156 8 0.0079 0.0043 0.0221 0.1946 b0.005
Zinc-binding cysteine 152 8 0.0076 0.0000 0.0455 0.0000 NS
GYDP strong turn 164–167 6 0.0048 0.0000 0.0174 0.0000 NS
TMHR 268–297 5 0.0225 0.0096 0.5631 0.0170 b0.001
CXXC in disulfide bond 212–215 10 0.0000 0.0000 0.0000 N/A NS
WAPE tetrapeptide 221–225 3 0.0056 0.0000 0.0289 0.0000 NS
SSSG strong turn 234–237 6 0.0083 0.0115 0.0000 N/A NS
Potential glycosylation sites 129–131, 203–205, 230–232,
251–253, 271–273, 287–289, 398–400
13 0.0332 0.0000 0.1493 0.0000 b0.001
gp30 Overall 302–515 0.0156 0.0056 0.0442 0.1267 b0.001
Fusion peptide 302–326 11 0.0163 0.0036 0.0433 0.0831 b0.001
4-3 Heptad repeat 332–383 7 0.0106 0.0002 0.0407 0.0049 b0.001
GD21 351–398 7 0.0169 0.0002 0.6833 0.0003 b0.001
CX6CC in disulfide bond 384–392 10 0.0062 0.0000 0.0375 0.0000 NS
Uncharged 20aa tract 438–457 16 0.0155 0.0016 0.0493 0.0325 b0.001
CTM 459–515 14 0.0232 0.0167 0.0411 0.4063 b0.001
PXXP in CTM 472–475, 492–495, 503–506 14, 17 0.0228 0.0000 0.0685 0.0000 b0.001
YXXL signaling motifs 487–490, 498–501, 508–511 9, 14, 17 0.0166 0.0000 0.5260 0.0000 b0.005
The p (probability) values (T≤ t) were determined using Wilcoxon matched pairs test.
NS: not significant (pN0.05).
Reference numbers represent: 1: Callebaut et al. (1991); 2: Callebaut et al. (1993); 3: Camargos et al. (2006); 4: Daniel et al. (1993); 5: Dube et al. (2000); 6: Gallaher et
al. (1995); 7: Gatot et al. (1998); 8: Gatot et al. (2002); 9: Inabe et al. (1999); 10: Johnston et al. (2002); 11: Kobe et al. (1999); 12: Mamoun et al. (1990); 13: NetNGlyc
prediction web server 1.0 (http://www.cbs.dtu.dk/services/NetNGlyc/); 14: Novakovic et al. (2004); 15. Portetelle et al. (1989); 16: Rice et al. (1984); 17: Willems et
al. (1995).
⁎ p values where PN (rate of non-synonymous substitution) was significantly higher than the rate of synonymous substitution PS (positive selection); otherwise, PN
was significantly lower than PS (negative selection).
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133, 134, 141, 144, and 181; Fig. 2) were mapped to the surface,
either on the front face or at the edge of the back face, and most
(except aa48) were overlapping with or spatially adjacent to
certain gp51 N-terminal immunostimulatory epitopes, indicating
possible biological importance of those frequent natural varia-
tions, e.g. ensuing conformational variability for immune escape.
A parallel model built with substitutions of the most frequent
natural variations (A48T, A73P, K74R, L80S, S82F, R121H,
Q132R, A133T, and N141D; Fig. 2) revealed subtle conforma-
tional difference from the wild type (Figs. 4A, B). Further
investigations would be needed to determine the possible
biological significance of such conformational difference.
An extensive functional study on BLV gp51 N-terminus
using introduced single-amino acid mutations demonstrated thatall of the functionally detrimental mutations mapped to the front
face (Johnston et al., 2002), with most of them close to or within
a gp51 functional domain, further supporting the biological
significance of the residues on the front face. However, none of
those detrimental, experimentally introduced mutations
occurred naturally in our sample pool which includes all
known full-length BLV env sequences to date, neither were they
located adjacent to the frequent natural variations based on our
structural model (data not shown). It is consistent with the idea
that function-abolishing mutations may be selected against in
the natural environment.
We also showed a model for the BLV gp30 external domain
(aa327–415) using homology alignment between HTLV-1 gp21
and BLV gp30 described by Kobe et al. (1999) and homology
modeling based on the crystal structure of HTLV-1 gp21
Table 3
Tests for evidence of selection on BLV env in each phylogenetic cluster
Cluster ONV PN PS PN/PS p values
(A) Leader peptide
US CA 0.0000 0.0000 0.0000 N/A NS
CR 0.0248 0.0160 0.0489 0.3271 0.0391
CONS 0.0037 0.0038 0.0033 1.1388 NS
EU 0.0241 0.0046 0.0802 0.0576 0.0156
(B) gp51 (surface glycoprotein)
US CA 0.0034 0.0004 0.0130 0.0313 NS
CR 0.0068 0.0042 0.0148 0.2842 0.0078
CONS 0.0029 0.0013 0.0078 0.1713 b0.0001
EU 0.0052 0.0027 0.0130 0.2089 0.0469
(C) gp30 (transmembrane glycoprotein)
US CA 0.0039 0.0000 0.0150 0.0000 NS
CR 0.0120 0.0042 0.0343 0.1229 0.0156
CONS 0.0030 0.0008 0.0095 0.0802 b0.0001
EU 0.0140 0.0067 0.0350 0.1901 0.0156
Phylogenetic clusters are shown in Fig. 3. The p (probability) values (T≤ t) were
determined using Wilcoxon matched pairs test.
NS: not significant (pN0.05); ONV: overall nucleotide variability; PN=the rate
of non-synonymous substitution; PS= the rate of synonymous substitution.
Fig. 4. Proposed space-filling models for the BLV gp51 N-terminus (A, B) and
gp30 external domain (C). Left column=front views, right column=back views.
(A) Model of the BLV gp51 N-terminus (aa34–185), showing locations of gp51
N-terminal epitopes, functional domains, and polymorphic informative (PI)
variation sites. Color annotations: E epitope: red; F epitope: blue; glycosylation
site: magenta; H epitope: olive green; ND1: orange; ND2: yellow; PI variation
sites: light green if not overlapped with epitopes, dark green if overlapped; zinc
binding peptide: turquoise. All G epitopes are among the PI variation sites and
shown in dark green. Bright green refers to the overlapped region between ND2
and zinc binding peptide. (B) Model of the BLV gp51 N-terminus (aa34–185)
with residue substitutions of the most frequent natural variations (A48T, A73P,
K74R, L80S, S82F, R121H, Q132R, A133T, and N141D). Locations of the same
epitopes, functional domains, and polymorphic informative (PI) variation sites
are shown as in (A). (C) Model of the BLV gp30 external domain (aa327–415).
Color annotations: 4-3 heptad repeat (leucine zipper): blue green; experimentally
introduced fusion-defective, infectivity-intact mutations (Gatot et al., 1998):
purple; glycosylation site: magenta; immunodominant cysteine residues: light
blue; immunosuppressive region: pink; PI variation sites: light green (none
overlapped with epitopes).
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(Kobe et al., 1999). The conformation we propose (Fig. 4C)
corresponds to the BLV TM model predicted using the
hydrophobic cluster analysis based on the coiled coil core
described for influenza Avirus hemagglutinin HA2 (Gatot et al.,
1998). This region (aa327–415) could be involved in cell
fusion, and the integrity of this coiled coil structure is essentialfor BLV Env protein multimerization (Gatot et al., 1998). Two
experimentally introduced mutations (A361Vand A365S; Gatot
et al., 1998), which affected fusion but not infectivity in vivo,
were not observed naturally in our sample pool and were
mapped adjacent to the leucine zipper (Fig. 2) on our model
(Fig. 4C). The predicted locations of immunosuppressive region
(aa361–381), immunodominant cysteine residues (C384, C391,
C392), and the polymorphic informative variable sites (aa329,
403, 404) were shown (Fig. 4C).
Natural deletion mutations were bounded by similar flanking
sequences and would result in truncations and aberrant coding
frames
Massive deletions in BLV env gene were detected in 3
Japanese isolates, where full-length env genes coexisted in the
same sample (Fig. 5A). Those three full-length env sequences
differed from each other and from all other env sequences in this
study (Fig. 2), making it unlikely that they represent cross-
contamination. Those natural deletions are summarized by
Table 4. In isolates JP AI-1 and JP EH-2, deletions resulted in
prematurely terminated gp51 transcript and questionable
expression of gp30 subunit due to frame shift, despite their
conserved gp30 coding sequences (Table 4; Figs. 5B, D). It
might be possible that they use alternative CTG start codons
(Table 4), which are readily used in BLV to initiate G4 gene
transcription, to generate full-length gp30 transcripts which
could then undergo cleavage at the normal cleavage site
(RVRR, aa298–301 in wild type) to release wild type gp30
peptides. In another isolate JP EH-1, deletions did not generate a
frame shift, thus resulting in an aberrant C-terminus of leader
peptide, missed middle segment of gp51, but intact gp30
subunit (Table 4; Fig. 5C). In each of those 3 isolates, the
nucleotide sequences flanking the upstream and downstream
deletion sites showed a high level of sequence similarity (Table
4). Likewise, in de novo deleted feline leukemia virus (FeLV)
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Table 4
Natural deletions in BLV env gene
Sample JP AI-1 JP EH-1 JP EH-2
Donor cattle breed Holstein Japanese black Japanese black
WBC at sample collection 9200 cells/mm3 14,100 cells/mm3 13,500 cells/mm3
Deleted region nt4870–5251 nt4848–5504 nt4960–5504
Deleted length 382nt 657nt 545nt
Upstream flanking sequence (UFS) nt4860–4869: atcatcagat nt4837–4847: ggtcccgaaga nt4959–4970: acagcatataac
Downstream flanking sequence (DFS) nt5242–5251: atcatcagat nt5486–5504: ggctcccgaaatattagta nt5501–5510: agtatataac
UFS/DFS identity 10/10 9/10 9/10
UFS/DFS unmatched gap 0 8 3
Leader peptide (LP) C-terminus missing C-terminus missing Intact
gp51 N-terminus missing, FS, and PMT N-terminus missing, C-terminus intact Middle part missing, FS, and PMT
gp30 CNS intact Intact CNS intact
In-frame ATG for gp30 None nt4821–4823 None
1st in-frame CTG for gp30 nt5322–5324 N/A nt5673–5675
pol stop codon Missing; (nt5315–5317) Missing; (nt5740–5742) Intact
pol encoded product Extra 20 amino acids Extra 70 amino acids Intact
rex/R3 5′ coding region Missing 3′ 2nt Missing 3′ 24nt Intact
rex/R3 SDS Missing; (nt5275–5277) Missing; (nt5568–5570) Intact
tax 5′ coding region Missing start codon Missing entire region Intact
tax SDS N/A N/A Intact
Three samples with a majority of SU (surface subunit) PCR products shorter than consensus are summarized. They also all showed coexisting full-length env
sequences (Fig. 5A).
CNS: coding nucleotide sequence; FS: frame shift; PMT: premature termination; SDS: splicing donor site; WBC: white blood cells.
First in-frame CTG alternative start codon refers to the first in-fame CTG triplet after the deletion site. Nucleotide positions in parentheses refer to the first possible
downstream alternative sites if the original sites are missing.
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the deletion were flanked by the same 6nt sequence (Shi and
Roy-Burman, 2000). This probably underlies a process of
internal deletion based on recombination induced by sequence
similarity; however, more evidence is needed to test this
possibility.
Deletions in the env region have been reported in endo-
genous retrovirus-like sequences, e.g., endogenous feline
retroviral species in cats (Reeves and O'Brien, 1984; Tchenio
and Heidmann, 1991). These have also been detected in other
retroviruses and were related to functional defectiveness, e.g. an
HIV-1 Env mutant with a deletion in its membrane-proximal
domain did not mediate cell fusion (Dimitrov et al., 2003).
Deletions of partial genome, especially env gene, have been
more frequently reported in leukemia/lymphoma-inducing
viruses, and such natural defective viral forms have been
related to malignant transformation. Examples include Rous
sarcoma virus with completely deleted env detected in chicken
sarcoma (Nunn et al., 1984), myoloproliferative leukemia virus
with deletion and rearrangement in env region detected in acute
leukemia (Penciolelli et al., 1987), Friend spleen focus-forming
virus with partial deletion and frame-shifting insertion in env
region detected in acute erythroleukemia in mice (Watanabe et
al., 1995), avian leucosis virus with multiple partial deletionsFig. 5. Natural deletion mutations in N-terminal Env transcripts. (A) Representative
gp51 (set 1 primer illustrated in Fig. 1). Expected size of amplified wild-type seque
subunit) PCR products shorter than consensus. All the other PCR amplifications (se
sizes. (B–D) Partial electropherograms showing the sequence reading spanning the de
sites of the deleted region (382 nt) in (B) are within nt4860–4869 and nt5242–5251
Numbers above each electropherogram indicate the nucleotide positions according to
termination sites are shown at the bottom. Bolded amino acids, corresponding to u
consensus.including env region detected in leukemia and bursal lymphoma
(Westaway et al., 1984; Goodenow and Hayward, 1987), and
feline leukemia virus with env truncation and recombination
detected in thymic and alimentary lymphosarcoma (Sheets et
al., 1993; Shi and Roy-Burman, 2000). For HTLV-1, which
belongs to the same genus Deltaretrovirus as BLV, proviral
deletions in env region have been detected in peripheral blood
cells of patients with T-cell prolymphocytic leukemia (Kojima
et al., 1998), with adult T-cell leukemia/lymphoma (Ohshima et
al., 1993), or with mycosis fungoides (Hall et al., 1991).
Although in previous studies, deleted mutants were found
coexisting with wild type viruses in tumor cells and not all the
tumor cells examined contained deleted mutants, those studies
still suggested a possible correlation between the env deletion
mutations and viral oncogenesis/leukemogenesis. For BLV,
natural env deletions have been rarely reported. One previous
report described a deletion around env region in infected cells
from enzootic bovine leucosis (Ogawa et al., 1987).
Deletion and associated frame shift could severely affect the
amino acid sequence, and thus the conformational structure, of
protein product. The three natural deletions observed in this
study would abolish the gp51 N-terminus RBD, whose wild
type conformational models are predicted in Fig. 4A. Altered
Env conformation or lack of Env expression on the surface ofgel of PCR amplification for the genomic segment encoding leader peptide and
nce is 935 bp. Arrowheads indicate the isolates with a majority of SU (surface
t 1 for other isolates and all of set 2) not shown here gave products of expected
leted genomic regions in the three isolates arrowheaded in (A). The start and end
, respectively, but are uncertain due to identical sequences flanking the deletion.
the reference BLV env sequence (K02120). Deduced amino acid sequences and
nderlined nucleotides, indicate where the deduced sequences are in frame with
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surveillance against the replicating viruses, a strategy widely
used in other retroviruses such as HIV-1 (Liu et al., 2006). Such
env-defective viruses would also be invisible in Env-targeting
serological diagnostic tests. They could be even undetectable in
PCR-based diagnostic screening if one or both of the paired
PCR primers were located within the deleted genomic region.
For example, the commonly used screening primer set
enclosing env segment nt5099–5542 (Fechner et al., 1997;
Licursi et al., 2002; Zaghawa et al., 2002; Asfaw et al., 2005;
Felmer et al., 2005) would not detect any of the three defective
forms reported here.
The coding sequence at the beginning of BLV env gene is
shared by several other genes (Fig. 1): rex and R3 (sharing
with env in nt4821–4871 in the same reading frame), pol
(sharing nt4821–4875, second reading frame), and tax
(sharing nt4868–4872, third reading frame). The deletions
in JP AI-1 and JP EH-1 occurred within this overlapping
coding region, resulting in abolished wild type pol stop
codon, deleted rex and R3 original splicing donor sites, and
missed initiating coding sequence for tax (Table 4). In
comparison, the deletion in isolate JP EH-2 (nt4960–5504)
reserved intact pol, rex, R3, and tax coding frames, although
frame-shifting for env (Fig. 5D; Table 4). Each of the three
bovine isolates containing env-deletion mutants contained
full-length LTR sequence (Zhao et al., 2007a) and pXBL
coding region (Zhao et al., 2007b). We were unable to test
any correlation between the env deletion mutants and host
health status in this study. None of our donor cattle were
reported to have malignancies at the time of sample
collection. We have peripheral leukocyte counts only for the
Japanese cattle, and the counts of the three with env deletions
did not differ significantly from those of cattle with no env
deletions (Table 4 and data not shown).
In summary, we added 28 new sequences to the current
literature of 16 full-length BLV env sequences, and presented
the most comprehensive population study to date for full-length
BLV env gene sequences. Analyses on BLV env-based
clustering (phylogeny, genotyping), sequence polymorphisms,
and possible selection patterns expand available literature and
provide information to help resolve certain controversial issues
(e.g., relative variability in different BLV env sub-coding
regions). The massive natural deletions observed in this study
might indicate the possible escape strategy of transformation-
competent, replication-defective BLV proviral species. Hope-
fully, our work would serve as the base for further functional
studies on deltaretroviral envelope genes/proteins.
Materials and methods
Cell culture and biological samples
BLV-producing cell lines FLK (fetal lamb kidney) (Van Der
Maaten and Miller, 1975) and Bat2Cl6 (bat lung epithelial)
(Graves and Ferrer, 1976) were maintained in Dulbecco's
modified Eagle's medium (Life Technologies, Inc.) with 2 mM
L-glutamine, 10 μg/ml insulin, 100 μg/ml streptomycin (Pfizer),100 U/ml penicillin, 50 U/ml polymyxin B and 10% fetal
bovine serum (FBS) (all from Sigma Chemical Co.). Cells were
grown at 37 °C in a moist atmosphere of 5% CO2 and passaged
at confluence. DNA samples US IA (from FLK) and US PA
(from Bat2Cl6) were extracted from cell lines, and the other US
(United States) and CR (Costa Rican) samples were genomic
DNA extracted from the peripheral blood leukocytes of BLV-
infected dairy cattle, using Qiagen DNeasy Tissue Kit (Qiagen).
Genomic DNA samples (containing proviral BLV DNA) BE
and JP (Japanese) series were generous gifts from other
researchers, obtained as already-extracted DNA. Standard
precautions were used to prevent molecular cross-contamina-
tion, including no DNA extraction or preparation of reaction
mixture in the laboratory used for post-PCR amplification work.
Polymerase chain reaction (PCR)
Nested PCR was used to amplify segments of the BLV env
region. All reagents except primers were from Promega
(Madison, WI, USA). The final reaction mixture (50 μl/sample)
contained 1× buffer, 2.0 mM MgCl2, 200 μM dNTPs, 200 μM
of each primer and 1.5 U Taq polymerase. Sterile hot start
reaction tubes (Molecular Bio Products) were used to reduce
non-specific binding. Primers (synthesized by Operon Bio-
technologies, Huntsville, AL, USA) (Fig. 1) are: Set 1: Out 5′
(nt4700–4720) CCGGGCAAAACAATCGTCGGT, Out 3′
(nt5810–5791) CTGATGGCTAAGGGCAGACA, In 5′
(nt4763–4778) CTCTCCTGGCTACTGA, In 3′ (nt5697–
5683) AGGAAGCCGTAGAGA; Set 2: Out 5′ (nt5600–
5617) ATGGCACCACCCTTCCCA, Out 3′ (nt6470–6454)
GAACTCGGTGCTGGCAG, In 5′ (nt5638–5651) CTCAA-
GGCAACGCC, In 3′ (nt6429–6414) CTGACTACTCCAC-
TAA. Primers labeled “Out” were used for the first round of
amplification, and those labeled “In” for the second round of
amplification and lie within the sequence amplified by the
“Out” primers. The cycle conditions were: 94 °C, 3 min; 30
(Out) or 42 (In) cycles of: 94 °C, 30 s; 54 °C (Out) or 49 °C (In),
45 s; 68 °C, 30 s; then 72 °C, 7 min. After amplification of 50 μl
reaction, 3 μl of product was checked by electrophoresis on a
1% agarose gel stained with 1% ethidium bromide and viewed
under UV light. The Zymo Spin PCR Purification kit (Zymo
Research Cooperation) was used to purify the products for
sequencing. At least three independent PCR products of each
amplified env segment were sequenced at the University of
California Sequencing Facility (Berkeley). The mixture sent for
direct sequencing was 6 μl of purified PCR product mixed with
0.5 μl of 5 μM sequencing primer: Set 1: 5′ (nt5144–5161)
TGATTGCGAGCCCCGATG, 3′ (nt5443–5425) GCCCGTG-
CTGTTTGATTTA; Set 2: 5′ (nt6013–6032) ATGACTCCAT-
TATCCTCCGC, 3′ (nt6150–6125) GGAACAGGCTTAGAAQ
TGAATG. Sequencing was conducted double-directionally, and
all sequences were also double-checked against their corre-
sponding electropherograms. For the sequence variations, only
those consistently shown in the sequences of all three replicates
were accepted as real variations rather than PCR errors.
Multiple sequences were aligned using the Gene Inspector
Program (Textco BioSoftware, Inc. West Lebanon, New
163X. Zhao, G.C. Buehring / Virology 366 (2007) 150–165Hampshire, USA). A consensus sequence was calculated based
on the individual set of input sequences.
Phylogenetic analyses, genotyping, and statistics
Phylogenetic trees were constructed using the Neighbor-
Joining method and the Minimum-Evolution method in MEGA
3.1 (Kumar et al., 2004), each with 1000 bootstrapping
replications. Genotyping based on deduced restriction fragment
length polymorphism (RFLP) using 444-bp partial BLV env
sequences was as described previously (Fechner et al., 1997;
Licursi et al., 2002). Statistic analyses were performed using
GraphPad InStat 3.06 (GraphPad Software, 2003). For
comparison of two paired, nonparametric groups of data points
(e.g. PN vs. PS in gp51), Wilcoxon matched pairs test was used.
For multiple comparison (e.g. variability in leader peptide vs.
gp51 vs. gp30), Friedman's test with Dunn's post test was used.
Synonymous and non-synonymous sites and substitutions were
determined using DnaSP 4.10 (Rozas et al., 2003).
Homology modeling and display
The conformation of the BLV gp51 N-terminus (aa34–185)
was predicted by homology alignment and modeling based on
the crystal structure of the receptor binding domain of ecotropic
Friend murine leukemia virus (F-MuLV) surface protein (Fass et
al., 1997; Molecular Modeling DataBase [MMDB] ID No.
22594), as described previously (Gatot et al., 2002; Johnston et
al., 2002). The conformation of BLV gp30 external domain
(aa327–415) was predicted by homology alignment and
modeling based on the crystal structure of HTLV-1 gp21
ectodomain (Kobe et al., 1999; MMDB ID No. 10056). The
aligned sequences were submitted to ESyPred3D Web Server
(http://www.fundp.ac.be/sciences/biologie/urbm/bioinfo/
esypred/) for homology modeling. The structural model PDB
files were viewed and annotated using DeepView Swiss-Pdb
Viewer (http://www.expasy.org/spdbv/).
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